Meropenem / Sulbactam Injection Suppliers & Bulk Manufacturers
Available Forms: injection
Available Strengths: 1 g / 500 mg, 1 g / 1 g, 2 g / 1 g
Reference Brands: Merosul (India/ LATAM), Merrem (USA/EU)
Category:
Nephrology
Antibiotics
Meropenem / Sulbactam Injection is available in injection
and strengths such as 1 g / 500 mg, 1 g / 1 g, 2 g / 1 g.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Meropenem / Sulbactam Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Meropenem / Sulbactam Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Meropenem / Sulbactam is a combination antibiotic used in hospitals to treat serious and complicated bacterial infections, particularly those caused by resistant organisms. The combination contains meropenem trihydrate, a broad-spectrum carbapenem antibiotic, and sulbactam sodium, a beta-lactamase inhibitor that helps protect the antibiotic from bacterial enzymes that can inactivate it. By combining these two components, the medicine enhances antibacterial activity and expands coverage against difficult-to-treat infections.
This injectable antibiotic is commonly used for conditions such as hospital-acquired pneumonia, complicated intra-abdominal infections, bloodstream infections, urinary tract infections, and severe skin and soft tissue infections. It is administered intravenously in hospital settings under medical supervision to ensure proper dosing and monitoring. Meropenem works by inhibiting bacterial cell wall synthesis, which leads to the destruction of bacteria, while sulbactam prevents certain bacteria from developing resistance mechanisms that reduce the effectiveness of the antibiotic.
Meropenem / Sulbactam injections are widely used in many countries, especially in Asia and emerging pharmaceutical markets, where they are supplied under different brand names such as Merosul and other regional brands. The medicine plays an important role in modern antimicrobial therapy, particularly in treating infections where standard antibiotics may not be effective.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing